Abstract
Purpose
Radiomics features (RFs) extracted from CT images may provide valuable information on the biological structure of ischemic stroke blood clots and mechanical thrombectomy outcome. Here, we aimed to identify RFs predictive of thrombectomy outcomes and use clot histomics to explore the biology and structure related to these RFs.
Methods
We extracted 293 RFs from co-registered non-contrast CT and CTA. RFs predictive of revascularization outcomes defined by first-pass effect (FPE, near to complete clot removal in one thrombectomy pass), were selected. We then trained and cross-validated a balanced logistic regression model fivefold, to assess the RFs in outcome prediction. On a subset of cases, we performed digital histopathology on the clots and computed 227 histomic features from their whole slide images as a means to interpret the biology behind significant RF.
Results
We identified 6 significantly-associated RFs. RFs reflective of continuity in lower intensities, scattered higher intensities, and intensities with abrupt changes in texture were associated with successful revascularization outcome. For FPE prediction, the multi-variate model had high performance, with AUC = 0.832 ± 0.031 and accuracy = 0.760 ± 0.059 in training, and AUC = 0.787 ± 0.115 and accuracy = 0.787 ± 0.127 in cross-validation testing. Each of the 6 RFs was related to clot component organization in terms of red blood cell and fibrin/platelet distribution. Clots with more diversity of components, with varying sizes of red blood cells and fibrin/platelet regions in the section, were associated with RFs predictive of FPE.
Conclusion
Upon future validation in larger datasets, clot RFs on CT imaging are potential candidate markers for FPE prediction.
Similar content being viewed by others
Data Availability
Data are available on reasonable request. The data are composed of deidentified participant data and can be obtained upon request from Dr Vincent Tutino at vincentt@buffalo.edu.
References
Riedel CH, Zimmermann P, Jensen-Kondering U, Stingele R, Deuschl G, Jansen O (2011) The importance of size: successful recanalization by intravenous thrombolysis in acute anterior stroke depends on thrombus length. Stroke 42(6):1775–1777
Benson JC, Fitzgerald ST, Kadirvel R, Johnson C, Dai D, Karen D et al (2020) Clot permeability and histopathology: is a clot’s perviousness on CT imaging correlated with its histologic composition? J Neurointerv Surg 12(1):38–42
Patel T, Fricano S, Waqas M, Tso M, Dmytriw A, Mokin M et al (2021) Increased perviousness on CT for acute ischemic stroke is associated with fibrin/platelet-rich clots. Am J Neuroradiol 42(1):57–64
Mokin M, Morr S, Natarajan SK, Lin N, Snyder KV, Hopkins LN et al (2015) Thrombus density predicts successful recanalization with Solitaire stent retriever thrombectomy in acute ischemic stroke. J Neurointerv Surg 7(2):104–107. https://doi.org/10.1136/neurintsurg-2013-011017
Mishra S, Dykeman J, Sajobi T, Trivedi A, Almekhlafi M, Sohn S et al (2014) Early reperfusion rates with IV tPA are determined by CTA clot characteristics. Am J Neuroradiol 35(12):2265–2272
Byun J-S, Nicholson P, Hilditch CA, Chun On Tsang A, Mendes Pereira V, Krings T et al (2019) Thrombus perviousness is not associated with first-pass revascularization using stent retrievers. Interv Neuroradiol 25(3):285–90
Patel TR, Waqas M, Sarayi S, Ren Z, Borlongan CV, Dossani R, et al (2021) Revascularization outcome prediction for a direct aspiration-first pass technique (ADAPT) from pre-treatment imaging and machine learning. Brain Sci 11(10) https://doi.org/10.3390/brainsci11101321
Aerts HJ, Velazquez ER, Leijenaar RT, Parmar C, Grossmann P, Carvalho S et al (2014) Decoding tumour phenotype by noninvasive imaging using a quantitative radiomics approach. Nat Commun 5(1):1–9
Gillies RJ, Kinahan PE, Hricak H (2016) Radiomics: images are more than pictures, they are data. Radiol 278(2):563–577
Qiu W, Kuang H, Nair J, Assis Z, Najm M, McDougall C et al (2019) Radiomics-based intracranial thrombus features on CT and CTA predict recanalization with intravenous alteplase in patients with acute ischemic stroke. AJNR Am J Neuroradiol 40(1):39–44. https://doi.org/10.3174/ajnr.A5918
Hofmeister J, Bernava G, Rosi A, Vargas MI, Carrera E, Montet X et al (2020) Clot-Based radiomics predict a mechanical thrombectomy strategy for successful recanalization in acute ischemic stroke. Stroke 51(8):2488–94. https://doi.org/10.1161/STROKEAHA.120.030334
Zaidat OO, Castonguay AC, Linfante I, Gupta R, Martin CO, Holloway WE et al (2018) First pass effect. Stroke 49(3):660–666. https://doi.org/10.1161/STROKEAHA.117.020315
Patel TR, Waqas M, Fricano S, Dmytriw A, Tomaszewski J, Levy E et al (2021) Clot organization on histology is associated with radiomics features that predict treatment outcomes from mechanical thrombectomy. SPIE, SPIE Medical Imaging
Fedorov A, Beichel R, Kalpathy-Cramer J, Finet J, Fillion-Robin J-C, Pujol S et al (2012) 3D Slicer as an image computing platform for the Quantitative Imaging Network. Magn Reson Imaging 30(9):1323–1341. https://doi.org/10.1016/j.mri.2012.05.001
Van Griethuysen JJ, Fedorov A, Parmar C, Hosny A, Aucoin N, Narayan V et al (2017) Computational radiomics system to decode the radiographic phenotype. Cancer Res 77(21):e104–e107
Yang Z-Y (2020) Development of a voxel-based radiomics calculation platform for medical image analysis. Duke University
Breiman L (2001) Random forests. Mach Learn 45(1):5–32
Santos EMM, Arrarte Terreros N, Kappelhof M, Borst J, Boers AMM, Lingsma HF et al (2021) Associations of thrombus perviousness derived from entire thrombus segmentation with functional outcome in patients with acute ischemic stroke. J Biomech 128:110700. https://doi.org/10.1016/j.jbiomech.2021.110700
Patel TR, Santo B, Monteiro A, Waqas M, Siddiqui AH, Tutino V (2021) Data-driven ischemic stroke clot phenotyping from whole-slide histopathology images. 2021 IEEE Western New York Image and Signal Processing Workshop (WNYISPW): IEEE 1–5
Patel TR, Waqas M, Fricano S, Dmytriw AA, Tomaszewski J, Levy EI, et al (2021) Clot organization on histology is associated with radiomics features that predict treatment outcomes from mechanical thrombectomy. Medical Imaging 2021: Digital Pathology: International Society for Optics and Photonics 116030L.
Patel TR, Santo BA, Jenkins TD, Waqas M, Monteiro A, Baig A, et al (2022) Biologically-informed clot histomics are predictive of acute ischemic stroke etiology. Stroke: Vascular and Interventional Neurol 2022;0:e000536. https://doi.org/10.1161/SVIN.122.000536
Fitzgerald S, Wang S, Dai D, Murphree DH Jr, Pandit A, Douglas A et al (2019) Orbit image analysis machine learning software can be used for the histological quantification of acute ischemic stroke blood clots. PLoS One 14(12):e0225841
Stritt M, Stalder AK, Vezzali E (2020) Orbit Image Analysis: an open-source whole slide image analysis tool. PLoS Comput Biol 16(2):e1007313
Roeder AH, Cunha A, Burl MC, Meyerowitz EM (2012) A computational image analysis glossary for biologists. Dev 139(17):3071–3080
Van der Walt S, Schönberger JL, Nunez-Iglesias J, Boulogne F, Warner JD, Yager N et al (2014) scikit-image: image processing in Python. PeerJ 2:e453
Bilgic AB, Gocmen R, Arsava EM, Topcuoglu MA (2020) The effect of clot volume and permeability on response to intravenous tissue plasminogen activator in acute ischemic stroke. J Stroke Cerebrovasc Dis 29(2):104541. https://doi.org/10.1016/j.jstrokecerebrovasdis.2019.104541
Dutra BG, Tolhuisen ML, Alves H, Treurniet KM, Kappelhof M, Yoo AJ et al (2019) Thrombus Imaging characteristics and outcomes in acute ischemic stroke patients undergoing endovascular treatment. Stroke 50(8):2057–2064. https://doi.org/10.1161/strokeaha.118.024247
Kyselyova AA, Fiehler J, Leischner H, Flottmann F, Buhk JH, Frölich AM (2021) Vessel diameter and catheter-to-vessel ratio affect the success rate of clot aspiration. Journal of NeuroInterventional Surgery. 2020:neurintsurg-2020–016459 https://doi.org/10.1136/neurintsurg-2020-016459.
Shin JW, Jeong HS, Kwon HJ, Song KS, Kim J (2018) High red blood cell composition in clots is associated with successful recanalization during intra-arterial thrombectomy. PLoS One 13(5):e0197492. https://doi.org/10.1371/journal.pone.0197492
Aliena-Valero A, Baixauli-Martín J, Torregrosa G, Tembl JI, Salom JB (2021) Clot composition analysis as a diagnostic tool to gain insight into ischemic stroke etiology: a systematic review. J Stroke 23(3):327
Xu R-G, Ariëns RA (2020) Insights into the composition of stroke thrombi: heterogeneity and distinct clot areas impact treatment. Haematologica 105(2):257
Mokin M, Waqas M, Fifi J, De Leacy R, Fiorella D, Levy EI, et al (2021) Clot perviousness is associated with first pass success of aspiration thrombectomy in the COMPASS trial. Journal of NeuroInterventional Surgery. 2020:neurintsurg-2020–016434 https://doi.org/10.1136/neurintsurg-2020-016434.
Sarioglu O, Sarioglu FC, Capar AE, Sokmez DF, Mete BD, Belet U (2022) Clot-based radiomics features predict first pass effect in acute ischemic stroke. Interv Neuroradiol 28(2):160–168. https://doi.org/10.1177/15910199211019176
van Voorst H, Bruggeman AAE, Yang W, Andriessen J, Welberg E, Dutra BG, et al (2022) Thrombus radiomics in patients with anterior circulation acute ischemic stroke undergoing endovascular treatment. Journal of NeuroInterventional Surgery. 2022:neurintsurg-2022–019085 https://doi.org/10.1136/jnis-2022-019085.
Liu Y, Brinjikji W, Abbasi M, Dai D, Arturo Larco JL, Madhani SI, et al (2021) Quantification of clot spatial heterogeneity and its impact on thrombectomy. J NeuroIntervl Surg neurintsurg-2021–018183 https://doi.org/10.1136/neurintsurg-2021-018183.
Ahn SH, Hong R, Choo IS, Heo JH, Nam HS, Kang HG et al (2016) Histologic features of acute thrombi retrieved from stroke patients during mechanical reperfusion therapy. Int J Stroke 11(9):1036–1044. https://doi.org/10.1177/1747493016641965
Berkhemer OA, Fransen PS, Beumer D, Van Den Berg LA, Lingsma HF, Yoo AJ, et al (2015) A randomized trial of intraarterial treatment for acute ischemic stroke. n Engl J Med 372:11–20
Goyal M, Demchuk AM, Menon BK, Eesa M, Rempel JL, Thornton J et al (2015) Randomized assessment of rapid endovascular treatment of ischemic stroke. N Engl J Med 372(11):1019–1030. https://doi.org/10.1056/NEJMoa1414905
Lee R, Adlam D, Clelland CA, Channon KM (2012) Lines of Zahn in coronary artery thrombus. Euro Heart J 33(9):1039
Santos EMM, Marquering HA, Berkhemer OA, van Zwam WH, van der Lugt A, Majoie CB et al (2014) Development and validation of intracranial thrombus segmentation on CT angiography in patients with acute ischemic stroke. PLoS One 9(7):e101985. https://doi.org/10.1371/journal.pone.0101985
Acknowledgements
We acknowledge the assistance of the Multispectral Imaging Suite and Histology Core Laboratory in the Dept. of Pathology & Anatomical Sciences, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo. The research reported in this publication was supported by the National Center for Advancing Translational Sciences of the National Institutes of Health under award number UL1TR001412 to the University at Buffalo. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH.
Funding
The research reported in this publication was supported by the National Center for Advancing Translational Sciences of the National Institutes of Health under award number UL1TR001412 to the University at Buffalo (Adnan H. Siddiqui). The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
TRP: None. BAS: None. AAB: None. MW: None. AM: None. EIL: Consulting fees: Claret Medical, GLG Consulting, Guidepoint Global, Imperial Care, Medtronic, Rebound, StimMed, Misionix, Mosiac, Clarion, IRRAS. Payment or honoraria for lectures, presentations, speakers’ bureaus, manuscript writing, or educational events: Medtronic; Payment for expert testimony: for rendering medical/legal opinions as an expert. Support for attending meetings and/or travel: Reimbursement for travel and food for some meetings with the CNS and ABNS. Stock or stock options: NeXtGen Biologics, RAPID Medical, Claret Medical, Cognition Medical, Imperative Care, Rebound Therapeutics, StimMed, Three Rivers Medical. AHS: Financial Interest/Investor/Stock Options/Ownership: Adona Medical, Inc., Amnis Therapeutics, Bend IT Technologies, Ltd., BlinkTBI, Inc, Buffalo Technology Partners, Inc., Cardinal Consultants, LLC, Cerebrotech Medical Systems, Inc, Cerevatech Medical, Inc., Cognition Medical, CVAID Ltd., Endostream Medical, Ltd, Imperative Care, Inc., Instylla, Inc., International Medical Distribution Partners, Launch NY, Inc., NeuroRadial Technologies, Inc., Neurotechnology Investors, Neurovascular Diagnostics, Inc., PerFlow Medical, Ltd., Q’Apel Medical, Inc., QAS.ai, Inc., Radical Catheter Technologies, Inc., Rebound Therapeutics Corp. (Purchased 2019 by Integra Lifesciences, Corp), Rist Neurovascular, Inc. (Purchased 2020 by Medtronic), Sense Diagnostics, Inc., Serenity Medical, Inc., Silk Road Medical, SongBird Therapy, Spinnaker Medical, Inc., StimMed, LLC, Synchron, Inc., Three Rivers Medical, Inc., Truvic Medical, Inc., Tulavi Therapeutics, Inc., Vastrax, LLC, VICIS, Inc., Viseon, Inc. Consultant/Advisory Board: Amnis Therapeutics, Apellis Pharmaceuticals, Inc., Boston Scientific, Canon Medical Systems USA, Inc., Cardinal Health 200, LLC, Cerebrotech Medical Systems, Inc., Cerenovus, Cerevatech Medical, Inc., Cordis, Corindus, Inc., Endostream Medical, Ltd, Imperative Care, Integra, IRRAS AB, Medtronic, MicroVention, Minnetronix Neuro, Inc., Penumbra, Q’Apel Medical, Inc., Rapid Medical, Rebound Therapeutics Corp., Serenity Medical, Inc., Silk Road Medical, StimMed, LLC, Stryker Neurovascular, Three Rivers Medical, Inc., VasSol, Viz.ai, Inc., W.L. Gore & Associates. National PI/Steering Committees: Cerenovus EXCELLENT and ARISE II Trial; Medtronic SWIFT PRIME, VANTAGE, EMBOLISE, and SWIFT DIRECT Trials; MicroVention FRED Trial & CONFIDENCE Study; MUSC POSITIVE Trial; Penumbra 3D Separator Trial, COMPASS Trial, INVEST Trial, MIVI neuroscience EVAQ Trial; Rapid Medical SUCCESS Trial; InspireMD C-GUARDIANS IDE Pivotal Trial. Board membership: Secretary, Society of NeuroInterventional Surgery (SNIS) Board of Directors. Grant Support: clinical and translational science institute grant from the National Center for Advancing Translational Sciences of the National Institutes of Health under award number UL1TR001412 to the University at Buffalo. VMT: Financial Interest/Investor/Stock Options/Ownership: Neurovascular Diagnostics, Inc., QAS.ai, Inc. Grant Support: Brain Aneurysm Foundation, National Science Foundation Award No. 1746694, NIH NINDS award R43 NS115314-0, clinical and translational science institute grant from the National Center for Advancing Translational Sciences of the National Institutes of Health under award number UL1TR001412 to the University at Buffalo.
Ethical approval
This study was approved by the University at Buffalo Human Research Institutional Review Board (study 00002092). We certify that the study was performed in accordance with the ethical standards described in the 1964 Declaration of Helsinki and its later amendments.
Informed consent
Informed consent was obtained from all individual participants included in the study.
Additional information
Publisher's note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Patel, T.R., Santo, B.A., Baig, A.A. et al. Histologically interpretable clot radiomic features predict treatment outcomes of mechanical thrombectomy for ischemic stroke. Neuroradiology 65, 737–749 (2023). https://doi.org/10.1007/s00234-022-03109-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00234-022-03109-2